Tuesday, June 18, 2019 9:00:03 AM
https://www.prnewswire.com/news-releases/avalon-globocare-expected-to-join-the-russell-3000-index-300870152.html
News provided by Avalon GloboCare Corp. Jun 18, 2019, 08:00 ET
FREEHOLD, N.J., June 18, 2019 /PRNewswire/ -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced that it expects to be added to the Russell 3000® Index, based on a preliminary list of additions posted June 7, 2019. Final inclusion in the Russell 3000® Index will be determined following completion of the annual Russell US Indexes Reconstitution, which occurs after the US equity markets close on Friday, June 28, 2019.
Indexes provided by FTSE Russell, a leading global index provider, are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against the Russell US Indexes. Membership in the Russell Microcap Index remains in place for one year and provides for automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
"We look forward to our inclusion in the Russell 3000® Index, which we believe reflects our continued growth and the progress we are making at Avalon," stated David Jin, M.D., Ph.D., CEO and President of Avalon GloboCare. "Inclusion in the Russell 3000® Index is expected to benefit our Company and shareholders by elevating our exposure within the global investment community."
JMHO. DYODD. "An investment in knowledge pays the best interest." - Benjamin Franklin
Recent ALBT News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:31:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 09:01:50 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/15/2024 08:05:29 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 09:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 12:29:00 PM
- Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device • GlobeNewswire Inc. • 08/14/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 12:18:14 PM
- Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction • GlobeNewswire Inc. • 07/31/2024 12:00:00 PM
- Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us • GlobeNewswire Inc. • 07/18/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 12:37:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:05:13 PM
- Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:54:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 09:10:10 PM
- Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report • GlobeNewswire Inc. • 05/24/2024 09:00:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 12:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:30:17 PM
- Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference • GlobeNewswire Inc. • 04/22/2024 01:00:00 PM
- Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union • GlobeNewswire Inc. • 03/28/2024 01:00:00 PM
- Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US • GlobeNewswire Inc. • 12/18/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:49:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:30:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:30:46 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 10/20/2023 08:18:23 PM
- Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis • GlobeNewswire Inc. • 10/18/2023 01:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM